We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$3.01B
AUM Growth
+$452M
Cap. Flow
+$517M
Cap. Flow %
17.18%
Top 10 Hldgs %
4.76%
Holding
1,615
New
563
Increased
594
Reduced
314
Closed
133

Top Buys

Rank Stock Value
1
MMS icon
Maximus
MMS
+$12.2M
2
CIVI
Civitas Resources
CIVI
+$11.9M
3
DCI icon
Donaldson
DCI
+$10.1M
4
SPB icon
Spectrum Brands
SPB
+$9.78M
5
PR
Permian Resources
PR
+$9.51M

Top Sells

Rank Stock Value
1
EME icon
Emcor
EME
+$16.9M
2
MSTR icon
Strategy Inc
MSTR
+$11.5M
3
SM icon
SM Energy
SM
+$10.1M
4
AA icon
Alcoa
AA
+$7.14M
5
WIRE
Encore Wire Corp
WIRE
+$6.98M

Sector Composition

Rank Sector Weight
1 Industrials 18.2%
2 Technology 14.94%
3 Financials 13.91%
4 Healthcare 13.14%
5 Consumer Discretionary 12.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KROS icon
776
Keros Therapeutics
KROS
$201M
$717K 0.02%
15,700
+1,505
+11% +$80.9K
NATL icon
777
NCR Atleos
NATL
$3.53B
$713K 0.02%
+26,397
New +$644K
MTDR icon
778
Matador Resources
MTDR
$6.55B
$712K 0.02%
+11,941
New +$750K
CTOS icon
779
Custom Truck One Source
CTOS
$2.47B
$711K 0.02%
163,463
-103,240
-39% -$503K
VERX icon
780
Vertex
VERX
$1.77B
$708K 0.02%
19,626
-17,904
-48% -$576K
ENSG icon
781
The Ensign Group
ENSG
$9.84B
$706K 0.02%
+5,707
New +$680K
SAGE
782
DELISTED
Sage Therapeutics
SAGE
$704K 0.02%
64,844
+39,114
+152% +$501K
WNC icon
783
Wabash National
WNC
$540M
$699K 0.02%
31,994
+16,404
+105% +$386K
CGEM icon
784
Cullinan Oncology
CGEM
$1.08B
$696K 0.02%
39,884
-39,796
-50% -$847K
DTM icon
785
DT Midstream
DTM
$14.8B
$694K 0.02%
+9,767
New +$641K
KSS icon
786
Kohl's
KSS
$2.06B
$694K 0.02%
+30,188
New +$729K
UFPI icon
787
UFP Industries
UFPI
$4.85B
$694K 0.02%
6,197
-37,762
-86% -$4.39M
CBSH icon
788
Commerce Bancshares
CBSH
$8.39B
$693K 0.02%
+13,699
New +$677K
DEI icon
789
Douglas Emmett
DEI
$2.03B
$691K 0.02%
51,916
+16,846
+48% +$228K
AIZ icon
790
Assurant
AIZ
$13.5B
$690K 0.02%
4,150
-8
-0.2% -$1.39K
MTN icon
791
Vail Resorts
MTN
$5.11B
$689K 0.02%
+3,824
New +$760K
IBCP icon
792
Independent Bank Corp
IBCP
$740M
$687K 0.02%
25,445
-181
-0.7% -$4.48K
BERY
793
DELISTED
Berry Global Group, Inc.
BERY
$687K 0.02%
+12,708
New +$690K
RHI icon
794
Robert Half
RHI
$4.06B
$677K 0.02%
+10,586
New +$726K
VERV
795
DELISTED
Verve Therapeutics
VERV
$671K 0.02%
+137,496
New +$864K
AGL icon
796
Agilon Health
AGL
$1.78B
$670K 0.02%
4,096
+3,274
+398% +$466K
HALO icon
797
Halozyme
HALO
$9.41B
$670K 0.02%
+12,791
New +$561K
AGNC icon
798
AGNC Investment
AGNC
$12.2B
$668K 0.02%
+70,037
New +$670K
CRSP icon
799
CRISPR Therapeutics
CRSP
$4.71B
$667K 0.02%
12,342
+3,832
+45% +$222K
AGX icon
800
Argan
AGX
$8.42B
$665K 0.02%
+9,093
New +$596K

Similar funds

Algert Global's Q2 2024 Portfolio in Review

As of Q2 2024, Algert Global held 1,615 positions worth $3.01B, up 18% from $2.55B the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Algert Global deployed $517M of net new capital in Q2 2024, opening 563 new positions and adding to 594 existing holdings. Its largest new stake was Maximus: 144,971 shares worth $12.4M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Emcor, an estimated $16.9M trimmed.

  • Algert Global's largest Q2 2024 buy was Maximus: 144,971 shares worth $12.4M.
  • Algert Global added most to Donaldson in Q2 2024, an estimated $10.1M increase.
  • Algert Global's biggest Q2 2024 reduction was Emcor, cutting an estimated $16.9M.
  • Algert Global fully exited Strategy Inc in Q2 2024, selling an estimated $11.5M.
  • Algert Global's ten largest holdings make up 4.8% of its $3.01B portfolio in Q2 2024.
  • Algert Global opened 563 new positions and closed 133 in Q2 2024.
  • Algert Global's portfolio value rose 18% quarter-over-quarter to $3.01B.

Based on Algert Global's 13F filing for Q2 2024, filed 15 Aug 2024.